A Study to Assess the Knowledge and Attitude on HPV vaccination among the faculty of Sharda University, Greater Noida, Uttar Pradesh with a view to develop information Booklet

Background: Human Papillomavirus (HPV) is the most common sexually transmitted infection worldwide and a leading cause of cervical cancer. Despite the availability of effective vaccines, uptake remains low in many regions, including India, due to limited awareness and cultural barriers. Faculty members in academic institutions play a vital role in influencing community health behaviors. This study aims to assess the knowledge and attitudes of Sharda University faculty toward HPV vaccination to support targeted educational interventions. Method and material: This descriptive study assessed the knowledge and attitudes of 101 faculty members at Sharda University toward HPV vaccination using an online structured questionnaire. Participants included faculty without prior HPV vaccine information, while vaccinated individuals were excluded. The questionnaire covered socio-demographics, knowledge questionnaire through 29 multiple- choice questions, and attitudes via a 15-item Likert scale. The tool was validated by experts to ensure accuracy and relevance. Result: The study revealed that most participants were young faculty members aged 25-30 years, predominantly female, and from allied sciences. A majority (69.3%) had poor knowledge of HPV vaccination, while only 19.8% showed good knowledge. Attitude toward HPV vaccination was largely negative, with 90.1% displaying unfavourable views. No significant association was found between knowledge levels and demographic variables such as age, gender, education, or vaccination status. Conclusion: The findings indicate a generally low level of knowledge and a predominantly negative attitude toward HPV vaccination among Sharda University faculty. This underscores the need for comprehensive educational programs targeting all demographic groups to raise awareness. Enhancing knowledge and attitudes is crucial to improve HPV vaccine acceptance and uptake in this population.